Are mutations of the TP53 tumour suppressor gene risk factors for prostate cancer formation?

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [11] Missense mutations in cancer suppressor gene TP53 are associated with Exonic Splicing Enhancers (ESEs)
    Gorlov, I
    Gorlova, O
    Frazier, M
    Amos, C
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 242 - 242
  • [12] Arrayed primer extension resequencing assay of TP53 tumour suppressor gene
    Roomere, H
    Meiel, A
    Tonisson, N
    Zernant, J
    Kurg, A
    Pavel, H
    Slavin, G
    Hainaut, P
    Metspalu, A
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 292 - 292
  • [13] Inherited TP53 Variants and Risk of Prostate Cancer
    Maxwell, Kara N.
    Cheng, Heather H.
    Powers, Jacquelyn
    Gulati, Roman
    Ledet, Elisa M.
    Morrison, Casey
    Le, Anh
    Hausler, Ryan
    Stopfer, Jill
    Hyman, Sophie
    Kohlmann, Wendy
    Naumer, Anne
    Vagher, Jennie
    Greenberg, Samantha E.
    Naylor, Lorraine
    Laurino, Mercy
    Konnick, Eric Q.
    Shirts, Brian H.
    AlDubayan, Saud H.
    Van Allen, Eliezer M.
    Nguyen, Bastien
    Vijai, Joseph
    Abida, Wassim
    Carlo, Maria, I
    Dubard-Gault, Marianne
    Lee, Daniel J.
    Maese, Luke D.
    Mandelker, Diana
    Montgomery, Bruce
    Morris, Michael J.
    Nicolosi, Piper
    Nussbaum, Robert L.
    Schwartz, Lauren E.
    Stadler, Zsofia
    Garber, Judy E.
    Offit, Kenneth
    Schiffman, Joshua D.
    Nelson, Peter S.
    Sartor, Oliver
    Walsh, Michael F.
    Pritchard, Colin C.
    EUROPEAN UROLOGY, 2022, 81 (03) : 243 - 250
  • [14] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [15] Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
    Mühlbauer, KR
    Gröne, HJ
    Ernst, T
    Gröne, E
    Tschada, R
    Hergenhahn, M
    Hollstein, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (04) : 687 - 690
  • [16] Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes
    K-R Mühlbauer
    H-J Gröne
    T Ernst
    E Gröne
    R Tschada
    M Hergenhahn
    M Hollstein
    British Journal of Cancer, 2003, 89 : 687 - 690
  • [17] TP53 gene mutations in plasma DNA of cancer patients
    Silva, JM
    Gonzalez, R
    Dominguez, G
    Garcia, JM
    España, P
    Bonilla, F
    GENES CHROMOSOMES & CANCER, 1999, 24 (02): : 160 - 161
  • [18] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [19] TP53 gene mutations as a prognostic marker for PSA progression in early stage prostate cancer
    Sachs, MD
    Schlechte, H
    Schiemenz, K
    Lenk, SV
    Schnorr, D
    Rudolph, BD
    Loening, SA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 282 - 282
  • [20] The tumor suppressor gene TP53: Implications for cancer management and therapy
    Seemann, S
    Maurici, D
    Olivier, M
    de Fromentel, CC
    Hainaut, P
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (5-6) : 551 - 583
12345